Single dose of baloxavir lowers the risk of influenza virus transmission to close contacts: NEJM Jacinthlyn Sylvia29 April 2025 9:15 AM ISTA new study published in The New England Journal of Medicine showed that a single dosage of the antiviral baloxavir marboxil (Xofluza) reduced the...
Conduct Phase III CT in Indian population: CDSCO Panel tells Roche Products India on Baloxavir marboxil Dr. Divya Colin6 March 2025 6:00 PM ISTNew Delhi: Noting that the Indian patient’s clinical data is not sufficient and acute uncomplicated influenza is not an unmet medical need, the...
Baloxavir Marboxil with lower hepatic toxicity safer option to oseltamivir in influenza patients with liver diseases: Study Jacinthlyn Sylvia20 May 2024 10:00 AM ISTA recent study published in the recent issue of BMC Infectious Diseases looked into the post-market safety profiles of two commonly prescribed...
Roche gets European Commission nod for Xofluza to treat influenza in children aged one year and above Ruchika Sharma17 Jan 2023 12:15 PM ISTInfluenza is a serious infectious disease and represents a significant threat to public health.
Roche Xofluza bags USFDA okay for influenza treatment in children aged five years and older Ruchika Sharma15 Aug 2022 4:00 PM ISTXofluza is available as a one-dose, single-tablet
FDA expands approval of baloxavir marboxil for post-exposure influenza prevention Dr. Kamal Kant Kohli24 Nov 2020 1:43 AM ISTThe US Food and Drug Administration (FDA) has expanded the indicated use of baloxavir marboxil (Xofluza) to include post-exposure influenza prevention...
